Per Johanson
BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 21, 2025
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Journal: European heart journal
Published: September 21, 2021
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
Journal: Journal of the American Heart Association
Published: August 23, 2021
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
Journal: Diabetes care
Published: June 02, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
Journal: Journal of the American Heart Association
Published: February 09, 2021
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.
Journal: Circulation
Published: September 05, 2020
Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Journal: Circulation
Published: August 16, 2020
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Journal: JAMA cardiology
Published: August 07, 2020
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Journal: Journal of the American Heart Association
Published: May 16, 2020
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Journal: Journal of the American Heart Association
Published: May 06, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Journal: JAMA
Published: March 29, 2020
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
Journal: Circulation
Published: September 03, 2019
Last Updated: 09/26/2026